DE60216482D1 - Zusammensetzungen und verfahren zum bestimmen von aa4rp - Google Patents
Zusammensetzungen und verfahren zum bestimmen von aa4rpInfo
- Publication number
- DE60216482D1 DE60216482D1 DE60216482T DE60216482T DE60216482D1 DE 60216482 D1 DE60216482 D1 DE 60216482D1 DE 60216482 T DE60216482 T DE 60216482T DE 60216482 T DE60216482 T DE 60216482T DE 60216482 D1 DE60216482 D1 DE 60216482D1
- Authority
- DE
- Germany
- Prior art keywords
- aa4rp
- compositions
- methods
- determining
- relates
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/775—Apolipopeptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0111598 | 2001-09-07 | ||
FR0111598A FR2829581A1 (fr) | 2001-09-07 | 2001-09-07 | Methodes de criblage de molecules utiles pour la prevention ou le traitement du syndrome metabolique, des maladies cardiovasculaires et de l'atherosclerose |
FR0210205 | 2002-08-12 | ||
FR0210205A FR2843395A1 (fr) | 2002-08-12 | 2002-08-12 | Composition et methodes pour le dosage de l'aa4rp |
PCT/FR2002/003041 WO2003023408A1 (fr) | 2001-09-07 | 2002-09-06 | Compositions et methodes pour le dosage de l'aa4rp |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60216482D1 true DE60216482D1 (de) | 2007-01-11 |
DE60216482T2 DE60216482T2 (de) | 2007-08-23 |
Family
ID=26213176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60216482T Expired - Fee Related DE60216482T2 (de) | 2001-09-07 | 2002-09-06 | Zusammensetzungen und verfahren zum bestimmen von aa4rp |
Country Status (10)
Country | Link |
---|---|
US (1) | US20040197823A1 (de) |
EP (1) | EP1423708B1 (de) |
JP (1) | JP2005502711A (de) |
AT (1) | ATE347108T1 (de) |
CA (1) | CA2459947A1 (de) |
DE (1) | DE60216482T2 (de) |
DK (1) | DK1423708T3 (de) |
ES (1) | ES2275924T3 (de) |
IL (1) | IL160531A0 (de) |
WO (1) | WO2003023408A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7972802B2 (en) * | 2005-10-31 | 2011-07-05 | University Of Washington | Lipoprotein-associated markers for cardiovascular disease |
US8241861B1 (en) | 2008-07-08 | 2012-08-14 | Insilicos, Llc | Methods and compositions for diagnosis or prognosis of cardiovascular disease |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001000806A2 (en) * | 1999-06-25 | 2001-01-04 | Genset | Dna's encoding proteins with signal peptides |
EP0976824A1 (de) * | 1998-07-10 | 2000-02-02 | Amsterdam Molecular Therapeutics | An der Leberregenration beteiligtes Gen und Protein |
US6455280B1 (en) * | 1998-12-22 | 2002-09-24 | Genset S.A. | Methods and compositions for inhibiting neoplastic cell growth |
AU1675900A (en) * | 1998-12-22 | 2000-07-12 | Genset | Complementary dna's encoding proteins with signal peptides |
ATE348108T1 (de) * | 1999-03-08 | 2007-01-15 | Genentech Inc | Methode zum nachweis von tumoren |
CA2311201A1 (en) * | 1999-08-05 | 2001-02-05 | Genset S.A. | Ests and encoded human proteins |
CA2406039A1 (en) * | 2000-04-14 | 2001-10-25 | Hyseq, Inc. | Materials and methods relating to lipid metabolism |
-
2002
- 2002-09-06 IL IL16053102A patent/IL160531A0/xx unknown
- 2002-09-06 ES ES02781373T patent/ES2275924T3/es not_active Expired - Lifetime
- 2002-09-06 US US10/487,096 patent/US20040197823A1/en not_active Abandoned
- 2002-09-06 AT AT02781373T patent/ATE347108T1/de not_active IP Right Cessation
- 2002-09-06 DK DK02781373T patent/DK1423708T3/da active
- 2002-09-06 EP EP02781373A patent/EP1423708B1/de not_active Expired - Lifetime
- 2002-09-06 WO PCT/FR2002/003041 patent/WO2003023408A1/fr active IP Right Grant
- 2002-09-06 DE DE60216482T patent/DE60216482T2/de not_active Expired - Fee Related
- 2002-09-06 JP JP2003527428A patent/JP2005502711A/ja active Pending
- 2002-09-06 CA CA002459947A patent/CA2459947A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20040197823A1 (en) | 2004-10-07 |
WO2003023408A1 (fr) | 2003-03-20 |
IL160531A0 (en) | 2004-07-25 |
DE60216482T2 (de) | 2007-08-23 |
ATE347108T1 (de) | 2006-12-15 |
ES2275924T3 (es) | 2007-06-16 |
EP1423708A1 (de) | 2004-06-02 |
DK1423708T3 (da) | 2007-04-02 |
EP1423708B1 (de) | 2006-11-29 |
JP2005502711A (ja) | 2005-01-27 |
CA2459947A1 (fr) | 2003-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1379693A4 (de) | Auf oligonukleotid-modifizierten partikeln basierende bio-strichcodes | |
DE69522831D1 (de) | Assays und vorrichtungen zum nachweis von extrahepatischer biliäreratresie | |
ATE540319T1 (de) | Verfahren für die bestimmung von fk506 | |
DE69333289D1 (de) | Verfahren zur bestimmung von säugetier nukleinsäuren aus stuhlproben und dafür benötigte reagenzien | |
ATE378404T1 (de) | Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon | |
WO2003043487A3 (en) | Method of using a non-antibody protein to detect and measure an analyte | |
DE60312513D1 (de) | Zusammensetzungen und verfahren zum nachweis vom apo-b48 und apo-b100 | |
BG104275A (en) | Method and device for express analysis of tested parameters in biological samples | |
ATE431854T1 (de) | Auf bio-barcodes beruhender nachweis von zielanalyten | |
ATE408829T1 (de) | Verfahren und assaykits zum nachweis mononuklearer zellphänotypen | |
DE69939121D1 (de) | Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden | |
ATE554106T1 (de) | Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung | |
ATE553216T1 (de) | Sonden, bibliotheken und kits zur analyse von nukleinsäuregemischen und verfahren zu deren konstruktion | |
CY1107621T1 (el) | Μεθοδος ανιχνευσης αντισωματων σε ενα δειγμα | |
AU3624199A (en) | Quantitative method for detecting nucleotide concentration | |
ATE220112T1 (de) | Verfahren zum nachweis von störungen des protein c/protein s-systems | |
DE60325382D1 (de) | Verfahren zur diagnose von gebärmutterhalskrebs | |
ATE416384T1 (de) | Verfahren und kit zum quantitativen und/oder qualitativen nachweis von komponenten in einer probe | |
DE60310012D1 (de) | Verfahren, Assay und Kit zur Quantifizierung von HIV-Proteasehemmer | |
DE50110174D1 (de) | Verfahren und testkit zum nachweis von analyten in einer probe | |
DE60228952D1 (de) | Nachweis von Legionella durch ein PCR und FRET verwendendes Verfahren | |
ATE462975T1 (de) | Verfahren zum immunochemischen testen des anti- hm1.24-antikörpers | |
DE602004017317D1 (de) | Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome | |
ATE449868T1 (de) | Methoden, testsätze und kompositionen zur detektion und quantifizierung von zielsequenzen | |
DE69428998D1 (de) | Reagenzien und verfahren zur detektion und quantitativen bestimmung von testosteron in flüssigen proben |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8381 | Inventor (new situation) |
Inventor name: NAJIB, JAMILA, MARRAKECH, MA Inventor name: MAJD, ZOUHER, F-59700 MARCQ EN BAROEUL, FR |
|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |